A detailed history of Hancock Whitney Corp transactions in Haleon PLC stock. As of the latest transaction made, Hancock Whitney Corp holds 11,240 shares of HLN stock, worth $109,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,240
Previous 10,984 2.33%
Holding current value
$109,027
Previous $90,000 31.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.32 - $10.7 $2,129 - $2,739
256 Added 2.33%
11,240 $118,000
Q2 2024

Aug 13, 2024

SELL
$8.01 - $8.64 $6,920 - $7,464
-864 Reduced 7.29%
10,984 $90,000
Q1 2024

May 16, 2024

BUY
$8.02 - $8.67 $4,050 - $4,378
505 Added 4.45%
11,848 $100,000
Q3 2023

Nov 13, 2023

SELL
$7.85 - $8.94 $989 - $1,126
-126 Reduced 1.1%
11,343 $94,000
Q2 2023

Aug 10, 2023

BUY
$8.04 - $9.0 $92,210 - $103,221
11,469 New
11,469 $96,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.